Indeed, we previously demonstrated, by western blot analysis, that CD133 is expressed at various levels in colon cancers[32,33] and that different results can be obtained by using different antibodies[34] and similar observations have been also reported by other Authors[35,36]. Here, PROM1 is linked to malignant colon neoplasm.